Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

The effectiveness of direct to healthcare professional communication - A systematic review of communication factor studies.

Møllebæk M, Kaae S, De Bruin ML, Callréus T, Jossan S, Hallgreen CE.

Res Social Adm Pharm. 2019 May;15(5):475-482. doi: 10.1016/j.sapharm.2018.06.015. Epub 2018 Jun 21. Review.

PMID:
31130181
2.

Body of evidence and approaches applied in the clinical development programme of fixed-dose combinations in the European Union from 2010 to 2016.

Nøhr-Nielsen A, De Bruin ML, Thomsen M, Pipper CB, Lange T, Bjerrum OJ, Lund TM.

Br J Clin Pharmacol. 2019 Aug;85(8):1829-1840. doi: 10.1111/bcp.13986. Epub 2019 Jun 17.

PMID:
31077427
3.

The EU regulatory landscape of non-biological complex drugs (NBCDs) follow-on products: Observations and recommendations.

Klein K, Stolk P, De Bruin ML, Leufkens HGM, Crommelin DJA, De Vlieger JSB.

Eur J Pharm Sci. 2019 May 15;133:228-235. doi: 10.1016/j.ejps.2019.03.029. Epub 2019 Apr 3.

PMID:
30953753
4.

Experiences of gender-based violence among female sex workers, men who have sex with men, and transgender women in Latin America and the Caribbean: a qualitative study to inform HIV programming.

Evens E, Lanham M, Santi K, Cooke J, Ridgeway K, Morales G, Parker C, Brennan C, de Bruin M, Desrosiers PC, Diaz X, Drago M, McLean R, Mendizabal M, Davis D, Hershow RB, Dayton R.

BMC Int Health Hum Rights. 2019 Mar 5;19(1):9. doi: 10.1186/s12914-019-0187-5.

5.

Adjusting for unmeasured confounding using validation data: Simplified two-stage calibration for survival and dichotomous outcomes.

Hjellvik V, De Bruin ML, Samuelsen SO, Karlstad Ø, Andersen M, Haukka J, Vestergaard P, de Vries F, Furu K.

Stat Med. 2019 Jul 10;38(15):2719-2734. doi: 10.1002/sim.8131. Epub 2019 Mar 3.

PMID:
30828842
6.

Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled "Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis".

Vignon Zomahoun HT, de Bruin M, Guillaumie L, Moisan J, Grégoire JP, Guénette L, Pérez N, Vézina-Im LA.

Value Health. 2019 Feb;22(2):264-266. doi: 10.1016/j.jval.2018.07.003. Epub 2018 Aug 9. No abstract available.

PMID:
30711074
7.

EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.

Hernandez G, Garin O, Dima AL, Pont A, Martí Pastor M, Alonso J, Van Ganse E, Laforest L, de Bruin M, Mayoral K, Serra-Sutton V, Ferrer M; ASTRO-LAB Group.

J Med Internet Res. 2019 Jan 23;21(1):e10178. doi: 10.2196/10178.

8.

Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: an ex vivo study.

Jelvehgaran P, Alderliesten T, Georgiou G, Meijer SL, Bloemen PR, Kodach LL, van Laarhoven HWM, van Berge Henegouwen MI, Hulshof MCCM, Rasch CRN, van Leeuwen TG, de Boer JF, de Bruin M, van Herk M.

Biomed Opt Express. 2018 Aug 14;9(9):4196-4216. doi: 10.1364/BOE.9.004196. eCollection 2018 Sep 1.

9.

Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.

Opstal-van Winden AWJ, de Haan HG, Hauptmann M, Schmidt MK, Broeks A, Russell NS, Janus CPM, Krol ADG, van der Baan FH, De Bruin ML, van Eggermond AM, Dennis J, Anton-Culver H, Haiman CA, Sawyer EJ, Cox A, Devilee P, Hooning MJ, Peto J, Couch FJ, Pharoah P, Orr N, Easton DF, Aleman BMP, Strong LC, Bhatia S, Cooke R, Robison LL, Swerdlow AJ, van Leeuwen FE.

Blood. 2019 Mar 7;133(10):1130-1139. doi: 10.1182/blood-2018-07-862607. Epub 2018 Dec 20.

PMID:
30573632
11.

Links Between Behavior Change Techniques and Mechanisms of Action: An Expert Consensus Study.

Connell LE, Carey RN, de Bruin M, Rothman AJ, Johnston M, Kelly MP, Michie S.

Ann Behav Med. 2019 Jul 17;53(8):708-720. doi: 10.1093/abm/kay082.

PMID:
30452535
12.

Behavior Change Techniques and Their Mechanisms of Action: A Synthesis of Links Described in Published Intervention Literature.

Carey RN, Connell LE, Johnston M, Rothman AJ, de Bruin M, Kelly MP, Michie S.

Ann Behav Med. 2019 Jul 17;53(8):693-707. doi: 10.1093/abm/kay078.

PMID:
30304386
13.

Hands washing, glove use, and avoiding recontamination before aseptic procedures at birth: A multicenter time-and-motion study conducted in Zanzibar.

Gon G, de Bruin M, de Barra M, Ali SM, Campbell OM, Graham WJ, Juma M, Nash S, Kilpatrick C, Penn-Kekana L, Virgo S, Woodd S.

Am J Infect Control. 2019 Feb;47(2):149-156. doi: 10.1016/j.ajic.2018.07.021. Epub 2018 Oct 4.

14.

Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation.

Wijnen BFM, Oberjé EJM, Evers SMAA, Prins JM, Nobel HE, van Nieuwkoop C, Veenstra J, Pijnappel FJ, Kroon FP, van Zonneveld L, van Hulzen AGW, van Broekhuizen M, de Bruin M.

Clin Infect Dis. 2019 Feb 1;68(4):658-667. doi: 10.1093/cid/ciy553.

PMID:
30239629
15.

Enhancing Behavior Change Technique Coding Methods: Identifying Behavioral Targets and Delivery Styles in Smoking Cessation Trials.

Black N, Williams AJ, Javornik N, Scott C, Johnston M, Eisma MC, Michie S, Hartmann-Boyce J, West R, Viechtbauer W, de Bruin M.

Ann Behav Med. 2019 May 3;53(6):583-591. doi: 10.1093/abm/kay068.

PMID:
30239563
16.

Pharmacist services for non-hospitalised patients.

de Barra M, Scott CL, Scott NW, Johnston M, de Bruin M, Nkansah N, Bond CM, Matheson CI, Rackow P, Williams AJ, Watson MC.

Cochrane Database Syst Rev. 2018 Sep 4;9:CD013102. doi: 10.1002/14651858.CD013102. Review.

PMID:
30178872
17.

Impact of asthma on women and men: Comparison with the general population using the EQ-5D-5L questionnaire.

Hernandez G, Dima AL, Pont À, Garin O, Martí-Pastor M, Alonso J, Van Ganse E, Laforest L, de Bruin M, Mayoral K, Ferrer M; ASTRO-LAB group.

PLoS One. 2018 Aug 23;13(8):e0202624. doi: 10.1371/journal.pone.0202624. eCollection 2018.

18.

Beliefs about back pain and pain management behaviours, and their associations in the general population: A systematic review.

Morton L, de Bruin M, Krajewska M, Whibley D, Macfarlane GJ.

Eur J Pain. 2019 Jan;23(1):15-30. doi: 10.1002/ejp.1285. Epub 2018 Aug 7.

19.

Postauthorization Changes to Specific Obligations of Conditionally Authorized Medicines in the European Union: A Retrospective Cohort Study.

Bloem LT, Mantel-Teeuwisse AK, Leufkens HGM, De Bruin ML, Klungel OH, Hoekman J.

Clin Pharmacol Ther. 2019 Feb;105(2):426-435. doi: 10.1002/cpt.1169. Epub 2018 Aug 12.

PMID:
29969839
20.

Ablation energies for focal treatment of prostate cancer.

Lodeizen O, de Bruin M, Eggener S, Crouzet S, Ghai S, Varkarakis I, Katz A, Dominguez-Escrig JL, Pahernik S, de Reijke T, de la Rosette J.

World J Urol. 2019 Mar;37(3):409-418. doi: 10.1007/s00345-018-2364-x. Epub 2018 Jun 25.

21.

Explaining the Amount and Consistency of Medical Care and Self-Management Support in Asthma: A Survey of Primary Care Providers in France and the United Kingdom.

de Bruin M, Dima AL, Texier N, van Ganse E; ASTRO-LAB group.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1916-1925.e7. doi: 10.1016/j.jaip.2018.04.039. Epub 2018 May 9.

PMID:
29753036
22.

A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making.

Coppens DGM, de Wilde S, Guchelaar HJ, De Bruin ML, Leufkens HGM, Meij P, Hoekman J.

Cytotherapy. 2018 Jun;20(6):769-778. doi: 10.1016/j.jcyt.2018.03.038. Epub 2018 May 2.

PMID:
29730080
23.

Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.

de Jong RGPJ, Peeters PJHL, Burden AM, de Bruin ML, Haak HR, Masclee AAM, de Vries F, Janssen-Heijnen MLG.

Cancer Epidemiol. 2018 Jun;54:104-111. doi: 10.1016/j.canep.2018.04.008. Epub 2018 May 16.

PMID:
29705628
24.

EU decision-making for marketing authorization of advanced therapy medicinal products: a case study.

de Wilde S, Coppens DGM, Hoekman J, de Bruin ML, Leufkens HGM, Guchelaar HJ, Meij P.

Drug Discov Today. 2018 Jul;23(7):1328-1333. doi: 10.1016/j.drudis.2018.03.008. Epub 2018 Mar 21. Review.

25.

Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction.

Rietbergen C, Stefansdottir G, Leufkens HG, Knol MJ, De Bruin ML, Klugkist I.

Front Med (Lausanne). 2018 Feb 22;4:228. doi: 10.3389/fmed.2017.00228. eCollection 2017.

26.

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors.

Bronsveld HK, De Bruin ML, Wesseling J, Sanders J, Hofland I, Jensen V, Bazelier MT, Ter Braak B, de Boer A, Vestergaard P, Schmidt MK.

BMC Cancer. 2018 Feb 27;18(1):224. doi: 10.1186/s12885-018-4072-8.

27.

Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.

Jelvehgaran P, Alderliesten T, Weda JJA, de Bruin M, Faber DJ, Hulshof MCCM, van Leeuwen TG, van Herk M, de Boer JF.

Med Phys. 2017 Dec;44(12):6570-6582. doi: 10.1002/mp.12624. Epub 2017 Nov 6.

PMID:
29023771
28.

Global Regulatory Differences for Gene- and Cell-Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation.

Coppens DGM, De Bruin ML, Leufkens HGM, Hoekman J.

Clin Pharmacol Ther. 2018 Jan;103(1):120-127. doi: 10.1002/cpt.894. Epub 2017 Nov 6. Review.

PMID:
28983911
29.

When More Is Less: An Exploratory Study of the Precautionary Reporting Bias and Its Impact on Safety Signal Detection.

Klein K, Scholl JHG, De Bruin ML, van Puijenbroek EP, Leufkens HGM, Stolk P.

Clin Pharmacol Ther. 2018 Feb;103(2):296-303. doi: 10.1002/cpt.879. Epub 2017 Oct 25.

PMID:
28913827
30.

Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.

Krul IM, Opstal-van Winden AWJ, Aleman BMP, Janus CPM, van Eggermond AM, De Bruin ML, Hauptmann M, Krol ADG, Schaapveld M, Broeks A, Kooijman KR, Fase S, Lybeert ML, Zijlstra JM, van der Maazen RWM, Kesminiene A, Diallo I, de Vathaire F, Russell NS, van Leeuwen FE.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):843-853. doi: 10.1016/j.ijrobp.2017.07.016. Epub 2017 Jul 18.

PMID:
28888722
31.

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.

van Eggermond AM, Schaapveld M, Janus CP, de Boer JP, Krol AD, Zijlstra JM, van der Maazen RW, Kremer LC, van Leerdam ME, Louwman MW, Visser O, De Bruin ML, Aleman BM, van Leeuwen FE.

Br J Cancer. 2017 Jul 25;117(3):306-314. doi: 10.1038/bjc.2017.177. Epub 2017 Jun 20.

32.

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.

But A, De Bruin ML, Bazelier MT, Hjellvik V, Andersen M, Auvinen A, Starup-Linde J, Schmidt MK, Furu K, de Vries F, Karlstad Ø, Ekström N, Haukka J.

Diabetologia. 2017 Sep;60(9):1691-1703. doi: 10.1007/s00125-017-4312-5. Epub 2017 Jun 1.

33.

What are the current challenges of managing cancer pain and could digital technologies help?

Adam R, de Bruin M, Burton CD, Bond CM, Giatsi Clausen M, Murchie P.

BMJ Support Palliat Care. 2018 Jun;8(2):204-212. doi: 10.1136/bmjspcare-2016-001232. Epub 2017 May 29.

34.

Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013.

Bouvy JC, Blake K, Slattery J, De Bruin ML, Arlett P, Kurz X.

Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1442-1450. doi: 10.1002/pds.4196. Epub 2017 Mar 26.

PMID:
28345151
35.

Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects.

Bhardwaj R, van der Meer A, Das SK, de Bruin M, Gascon J, Wolterbeek HT, Denkova AG, Serra-Crespo P.

Sci Rep. 2017 Mar 13;7:44242. doi: 10.1038/srep44242.

36.

Predicting adherence to combination antiretroviral therapy for HIV in Tanzania: A test of an extended theory of planned behaviour model.

Banas K, Lyimo RA, Hospers HJ, van der Ven A, de Bruin M.

Psychol Health. 2017 Oct;32(10):1249-1265. doi: 10.1080/08870446.2017.1283037. Epub 2017 Feb 13.

PMID:
28276745
37.

Measuring medication adherence in asthma: Development of a novel self-report tool.

Dima AL, van Ganse E, Laforest L, Texier N, de Bruin M; The Astro-Lab Group.

Psychol Health. 2017 Oct;32(10):1288-1307. doi: 10.1080/08870446.2017.1290248. Epub 2017 Feb 20.

PMID:
28276742
38.

Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial.

de Bruin M, Oberjé EJM, Viechtbauer W, Nobel HE, Hiligsmann M, van Nieuwkoop C, Veenstra J, Pijnappel FJ, Kroon FP, van Zonneveld L, Groeneveld PHP, van Broekhuizen M, Evers SMAA, Prins JM.

Lancet Infect Dis. 2017 Jun;17(6):595-604. doi: 10.1016/S1473-3099(16)30534-5. Epub 2017 Mar 3.

PMID:
28262598
39.

Trends in breast cancer incidence among women with type-2 diabetes in British general practice.

Bronsveld HK, Peeters PJHL, de Groot MCH, de Boer A, Schmidt MK, De Bruin ML.

Prim Care Diabetes. 2017 Aug;11(4):373-382. doi: 10.1016/j.pcd.2017.02.001. Epub 2017 Feb 23.

PMID:
28237628
40.

Diabetes and Breast Cancer Subtypes.

Bronsveld HK, Jensen V, Vahl P, De Bruin ML, Cornelissen S, Sanders J, Auvinen A, Haukka J, Andersen M, Vestergaard P, Schmidt MK.

PLoS One. 2017 Jan 11;12(1):e0170084. doi: 10.1371/journal.pone.0170084. eCollection 2017.

41.

Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.

Knapen LM, de Jong RG, Driessen JH, Keulemans YC, van Erp NP, De Bruin ML, Leufkens HG, Croes S, de Vries F.

Diabetes Obes Metab. 2017 Mar;19(3):401-411. doi: 10.1111/dom.12833. Epub 2017 Feb 7.

PMID:
27883260
42.

Can patient-reported measurements of pain be used to improve cancer pain management? A systematic review and meta-analysis.

Adam R, Burton CD, Bond CM, de Bruin M, Murchie P.

BMJ Support Palliat Care. 2017 Dec;7(4):0. doi: 10.1136/bmjspcare-2016-001137. Epub 2016 Nov 22. Review.

PMID:
27879472
43.

Environmental interventions for altering eating behaviours of employees in the workplace: a systematic review.

Allan J, Querstret D, Banas K, de Bruin M.

Obes Rev. 2017 Feb;18(2):214-226. doi: 10.1111/obr.12470. Epub 2016 Nov 17. Review.

PMID:
27860169
44.

Lessons learned on the design and the conduct of Post-Authorization Safety Studies: review of 3 years of PRAC oversight.

Engel P, Almas MF, De Bruin ML, Starzyk K, Blackburn S, Dreyer NA.

Br J Clin Pharmacol. 2017 Apr;83(4):884-893. doi: 10.1111/bcp.13165. Epub 2016 Dec 7.

45.

What We Mean When We Talk About Adherence in Respiratory Medicine.

Vrijens B, Dima AL, Van Ganse E, van Boven JF, Eakin MN, Foster JM, de Bruin M, Chisholm A, Price D.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):802-12. doi: 10.1016/j.jaip.2016.05.019. Review.

46.

From Theory-Inspired to Theory-Based Interventions: A Protocol for Developing and Testing a Methodology for Linking Behaviour Change Techniques to Theoretical Mechanisms of Action.

Michie S, Carey RN, Johnston M, Rothman AJ, de Bruin M, Kelly MP, Connell LE.

Ann Behav Med. 2018 May 18;52(6):501-512. doi: 10.1007/s12160-016-9816-6.

47.

Mapping the Asthma Care Process: Implications for Research and Practice.

Dima AL, de Bruin M, Van Ganse E; ASTRO-LAB group.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):868-76. doi: 10.1016/j.jaip.2016.04.020. Epub 2016 Jun 7.

48.

Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.

Afghahi A, Mathur M, Thompson CA, Mitani A, Rigdon J, Desai M, Yu PP, de Bruin MA, Seto T, Olson C, Kenkare P, Gomez SL, Das AK, Luft HS, Sledge GW Jr, Sing AP, Kurian AW.

J Oncol Pract. 2016 Jun;12(6):e697-709. doi: 10.1200/JOP.2015.009803. Epub 2016 May 24.

49.

Insulin glargine use and breast cancer risk: Associations with cumulative exposure.

Peeters PJ, Bazelier MT, Leufkens HG, Auvinen A, van Staa TP, de Vries F, De Bruin ML.

Acta Oncol. 2016 Jul;55(7):851-8. doi: 10.3109/0284186X.2016.1155736. Epub 2016 May 6.

50.

Identifying effective behavioural components of Intervention and Comparison group support provided in SMOKing cEssation (IC-SMOKE) interventions: a systematic review protocol.

de Bruin M, Viechtbauer W, Eisma MC, Hartmann-Boyce J, West R, Bull E, Michie S, Johnston M.

Syst Rev. 2016 May 4;5:77. doi: 10.1186/s13643-016-0253-1.

Supplemental Content

Loading ...
Support Center